Professional Documents
Culture Documents
Drug Study Files
Drug Study Files
CONSIDERATION
Generic Name: Citicoline Citicoline consumption - Cerebrovascular diseases – Hypersensitivity Fleeting and Instruct patient to
Brand Name: Cognizin, promotes brain metabolism
Somazine by restoring phospholipid e.g. from ischaemia due Patients with discrete take the
Classification: content in the brain and to stroke, where Citicoline hypertonic of the hypotension effect medication as
Doctor’s Order: regulation of neuronal
membrane excitability. It also accelerates the recovery of parasympathetic. Increased prescribed.
influences the mitochondria consciousness and parasympathetic Teach the patient
or energy factories of the
overcoming motor deficit. effects that citicoline may
brain cells and found to
improve memory function. Hypotension be taken with or
After several clinical trials, - Head Trauma of varying Itching or hives without food.
Citicoline has been shown to
raise the amount of severity: In a clinical trial, Swelling in face Monitor for
acetylcholine in the brain. Citicoline accelerated the or hands adverse effects;
recovery from post-traumatic Chest tightness instruct patient to
coma and the recuperation of Tingling in mouth report
walking ability, achieved a and throat immediately if
better final functional result Headache he/she develops
and reduced hospital stay. Nausea chest tightness,
Diarrhea tingling in mouth
Blurred Vision and throat,
headache,
diarrhea and
blurring of vision.
Referrence: Citicoline (Ceraxon) Drug Information – Indications, Dosage, Side Effects and Precautions (n.d.).Retrieved from http://www.medindia.net/doctors/drug_information/ citicoline.htm#ixzz378wmysaB .
NAME OF DRUGS MODE OF ACTION INDICATIONS CONTRAINDICATIONS ADVERSE EFFECT NURSING CONSIDERATION
Generic Name: Enters target cells and Replacement therapy in adrenal Systemic administration: -Vertigo Systemic administration
Hydrocortisone binds to cytoplasmic cortical insufficiency infections, especially -Headache · Give daily before 9 AM to
Brand Name: Ala-cort, receptors; initiates · Hypercalcemia associated with tuberculosis, fungal -Paresthesias mimic normal peak diurnal
Cipro, Colocort many complex cancer infections, amebiasis, -Insomnia corticosteroid levels and minimize
Classification: reactions that are · Short-term inflammatory and hepatitis B, vaccinia, or -Convulsions HPA suppression.
Corticosteroid
responsible for its allergic disorders, such as varicella, and antibiotic- -Psychosis · Space multiple doses evenly
Doctor’s Order:
anti-inflammatory, rheumatoid arthritis, collagen resistant infections; kidney -Hypotension throughout the day.
immunosuppressive diseases (SLE), dermatologic disease (risk to edema); -Shock · Do not give IM injections if
(glucocorticoid), and diseases (pemphigus), status liver disease, cirrhosis, -Hypertension patient has thrombocytopenic
salt-retaining asthmaticus, and autoimmune hypothyroidism; ulcerative -CHF secondary to purpura.
(mineralocorticoid) disorders colitis with impending fluid retention · Rotate sites of IM repository
actions. Some actions · Hematologic disorders-- perforation; diverticulitis; -Thromboembolism injections to avoid local atrophy.
may be undesirable, thrombocytopenic purpura, recent GI surgery; active or -Thrombophlebitis · Use minimal doses for minimal
depending on drug erythroblastopenia latent peptic ulcer; -Fat embolism duration to minimize adverse
use. · Trichinosis with neurologic or inflammatory bowel -Cardiac arrhythmias effects.
myocardial involvement disease (risks exacerbations secondary to · Taper doses when discontinuing
· Ulcerative colitis, acute or bowel perforation); electrolyte high-dose or long-term therapy.
exacerbations of multiple sclerosis, hypertension, CHF; disturbances · Arrange for increased dosage
and palliation in some leukemias thromboembolitic when patient is subject to unusual
and lymphomas tendencies, stress.
· Intra-articular or soft-tissue thrombophlebitis, · Use alternate-day maintenance
administration: Arthritis, psoriatic osteoporosis, convulsive therapy with short-acting
plaques disorders, metastatic corticosteroids whenever possible.
· Retention enema: For ulcerative carcinoma, diabetes · Do not give live virus vaccines
colitis, proctitis mellitus; lactation. with immunosuppressive doses of
· hydrocortisone.
· Provide antacids between meals
to help avoid peptic ulcer.
Referrence: Nurse's Notes: Hydrocortisone Drug Study (nurse-sha.blogspot.com)
NAME OF DRUGS MODE OF ACTION INDICATIONS CONTRAINDICATIONS ADVERSE NURSING CONSIDERATION
EFFECT
Generic Name: Epinephrine Stimulates alpha-, beta-, Temporary relief of Older adult or debilitated Nervousness, - Monitor BP, pulse, respirations, and urinary output
Brand Name: Adrenalin and beta- bronchospasm, acute patients; prostatic restlessness,
Classification: Adrenergic adrenergic receptors asthmatic attack, mucosal hypertrophy; hypertension; sleeplessness, and observe patient closely following IV
Agonist Agent, resultingin relaxation of congestion, diabetes mellitus; fear, anxiety, administration. Epinephrine may widen pulse pressure.
Bronchodilator smooth muscle of the hypersensitivity and hyperthyroidism; tremors, severe
Doctor’s Order: bronchial tree, cardiac anaphylactic reactions, Parkinson’s disease; headache, If disturbances in cardiac rhythm occur, withhold
stimulation, syncope due to heart tuberculosis; cerebrovascular epinephrine and notify physician immediately.
anddilation of skeletal block or carotid sinus psychoneurosis; in patients accident,
- Keep physician informed of any changes in intake-
vasculature; small hypersensitivity, and to with long-standing weakness,
doses can cause restore cardiac rhythm in bronchial asthma and dizziness, output ratio.
vasodilation via beta cardiac arrest. emphysema with syncope, pallor, - Use cardiac monitor with patients receiving
vascular receptors; l degenerative heart disease; sweating,
arge doses may prod in children <6 y of age. dyspnea. epinephrine IV. Have full crash cart immediately
uce constriction of s available.
k e l e t a l a n d vascular
smooth muscle; decreases - Check BP repeatedly when epinephrine is
production of aqueous administered IV during first 5 min, then q3–5min until
humor and
stabilized.
increasesaqueous outflow;
dilates the pupil by contracting - Advise patient to report to physician if symptoms are
the dilator muscle not relieved in 20 min or if they become worse
following inhalation.
- Advise patient to report bronchial irritation,
nervousness, or sleeplessness. Dosage should be
reduced.
- Monitor blood glucose & HbA1c for loss of
glycemic control if diabetic.
Subjective : “ One week Ineffective breathing Exposure to environmental Goal: After 4 hours of -Identify and eliminate the - To be able to reduce Goal partially met
na po akong may dry pattern related to factors such as cold, nursing intervention presence of environmental patients exposure to After 4 hours of nursing
cough at plema , usually smooth muscle smoking,and pollutants patient will factors triggers intervention the patient
po nacacause ng dust constriction of the ↓ demonstrate an was able to demonstrate
yung asthma ko” bronchioles IgE antibodies are produced as improved ventilation -Assess respiratory rate and -To determine if there is decreased signs of
an immune response and adequate depth and inspect nailbeds presence of cyanosis respiratory distress.
Objective : ↓ oxygenation of tissues and buccal membrane
- Patient is conscious and IgE attaches to the mast cells and absence of signs of
able to speak of the lungs respiratory distress -Auscultate breath sounds -To note for adventitious
-Oriented to time, person ↓ breath sounds as well as
and place Re-exposure to antigens in the fremitus.
-Ambulatory environment results in the
-Dry coughing -Assess level of -To evaluate cerebral
antigen binding to the antibody
-Wheezy breathing consciousness and perfusion
↓
mentality changes
Mast cell products(chemical
Vital Signs: mediators)are released –
02 sat.:96% -Monitor Vital Signs -To assess the severity of
histamine,
PR: 86 patient’s condition
bradykinin,prostaglandin -Elevate head of the bed To ma-intain airway
RR:20 ↓ and position appropriately
T:36.9 Mediators affects smooth
BP:110/80 mmHg muscles causing -Encourage deep breathing -To promote optional
bronchospasm and mucous exercises chest expansion
membrane swelling
↓ -Encourage rest and limit -To prevent exhaustion
Airways are obstructed activities and promote
↓ restful environment
Passage of O2and CO2
between the alveoli and -Administer medications as -To dilate bronchial
vascular system are decreased indicated ( bronchodilators, smooth muscles and
antibiotics, corticosteroids) facilitate respirtaion
DATE/TIME FOCUS NURSES NOTES PROGRESS NOTE
07/05/2022 @ 1:16 pm Monitoring Vital Signs Vital sign DATA: Received a 15 years old patient
02 sat.:96% lying on bed , conscious and
PR: 86 conversant with a heplock on his left
RR:20 hand metacarpal.
T:36.9
BP:110/80 mmHg ACTION:
Assess the patients status
Took and recorded vital signs
Monitor 02 sat
Ensure safety(raising side rails of
bed)
Position in a comfortable position
( Semi-fowlers)
Health teaching (deep breathing
exercise, best position, avoidance of
the allergens)
RESPONSE:
02sat of 96%
Still with heplock
Still sitting semi-fowlers on bed
Was able to learn and perform
proper deep breathing exercise, knows
the best position in bed and avoidance
of allergens.